steroid
indic
seriou
infecti
diseas
sever
acut
respiratori
syndrom
sar
acquir
immur
defici
syndrom
chronic
autoimmun
diseas
system
lupu
erythematosu
rheumatoid
arthriti
howev
steroidassoci
osteonecrosi
frequent
occur
highli
desir
develop
agent
could
prevent
occurr
due
gener
poor
surgic
prognosi
etiopathogenesi
steroidassoci
recent
explain
intravascular
thrombosi
induc
occlus
extravascular
lipiddeposit
induc
pressur
lead
impair
intraoss
blood
suppli
endothelium
injuri
predispos
hypercoagul
hypofibrinolysi
consist
present
intravascular
event
elev
adipogenesi
involv
extravascular
event
although
experiment
confirm
combin
administr
anticoagul
lipidlow
agent
may
help
prevent
steroidassoci
ideal
strategi
would
simultan
target
intravascular
thrombosi
extravascular
lipid
deposit
prevent
steroidassoci
develop
author
clinic
epidemiolog
data
show
lower
preval
found
patient
recov
sar
frequent
prescrib
crude
extract
flavonoid
rich
bone
strengthen
herb
epimedium
rehabilit
southern
china
wherea
higher
preval
found
seldom
prescrib
crude
extract
epimedium
northern
china
recent
use
small
scale
laboratori
isol
procedur
bone
strengthen
herb
epimedium
deriv
flavonoid
show
benefici
effect
prevent
steroidassoci
inhibit
intravascular
thrombosi
extravascular
lipiddeposit
establish
rabbit
model
singl
dose
studi
design
simplifi
procedur
isol
flavonoid
herbal
epimedium
meet
requir
larg
scale
product
establish
intern
applic
number
issu
world
intellectu
properti
organ
gener
seven
major
flavonoid
compound
common
stem
nuclear
character
high
perform
liquid
chromatographi
hplc
profil
figur
accord
recent
find
diversiform
isoflavon
common
stem
nuclei
may
intestin
metabol
equal
act
pharmacolog
target
predict
seven
flavonoid
glycosid
common
stem
nuclei
ef
could
final
intestin
metabol
uniform
molecul
detect
serum
date
avail
studi
address
doseeffect
pattern
activ
substanc
basi
ef
obtain
simplifi
isol
procedur
accordingli
follow
two
specif
experi
design
present
studi
studi
use
establish
rabbit
model
examin
effect
ef
differ
dosag
haematolog
indic
intravascular
thrombosi
extravascular
lipiddeposit
well
histopatholog
indic
lesion
intravascular
thrombosi
extravascular
lipiddeposit
respect
prototyp
metabolit
ef
serum
also
examin
high
perform
liquid
chromatographi
hplc
ultraviolet
uv
electrospray
ionizationion
trap
mass
spectrometri
ms
studi
ii
use
human
umbil
vein
endotheli
cell
model
preadipocyt
model
vitro
detect
prevent
effect
icaritin
detect
metabolit
ef
well
seven
prototyp
flavonoid
glycosid
endotoxininduc
endotheli
cell
damag
steroidinduc
lipid
deposit
respect
one
hundr
twelv
male
newzealand
white
rabbit
bodi
weight
kg
hous
laboratari
anim
servic
center
princ
wale
hospit
affili
hospit
chines
univers
hong
kong
anim
receiv
standard
laboratori
diet
water
ad
lititum
experiment
protocol
approv
anim
experi
ethic
committe
authro
institut
hong
kong
ref
base
establish
protocol
induc
steroidassoci
rabbit
intraven
inject
lippolysaccharid
lp
escherichia
coli
sigmaaldrich
inc
usa
day
week
hour
later
three
inject
mg
methylprednisolon
mp
pharmacia
upjohn
usa
given
intramuscularli
time
interv
hour
simultan
rabbit
divid
group
follow
daili
oral
administr
low
dose
ef
group
lef
n
mg
middl
dose
ef
group
mef
n
mg
high
dose
ef
group
hef
n
mg
control
group
receiv
correspond
vehicl
ef
daili
con
n
week
baselin
immedi
lp
inject
post
induct
ml
blood
sampl
collect
plasma
serum
prepar
evalu
endothelium
damag
index
tm
thrombomodulin
use
establish
protocol
detect
prototyp
metabolit
ef
respect
addit
serum
hepatocyt
injur
indic
includ
alanin
aminitransperas
alt
aspart
aminotransferas
ast
examin
evalu
potenti
hepatocyt
toxic
ef
marrow
sampl
iliac
crest
also
obtain
local
evalu
adipogen
potenti
index
mesenchym
stem
cell
adipocyt
positvi
coloni
hand
dynamiccontrastenhanc
mri
perform
proxim
femur
intraoss
perfus
function
index
pep
ie
peak
enhanc
percentag
sacrific
baselin
week
week
postinduct
use
bolu
dimeglumin
gadopentet
magnevist
schere
berlin
germani
establish
protocol
serum
examin
either
prototyp
metabolit
ef
serum
obtain
centrifug
revolut
per
minut
rpm
min
store
analysi
serum
sampl
thaw
room
temperatur
analyt
extract
ml
serum
aliquot
liquidliquid
partit
use
watersatur
ethyl
acet
ethyl
acet
partit
dri
gentli
blow
nitrogen
ga
room
temperatur
residu
redissolv
inject
perform
liquid
chromatographytandem
mass
spectrometri
hplcmsm
analysi
use
hplc
system
coupl
uvdad
ultraviolet
system
esi
ion
trap
mass
spectrometri
lc
separ
conduct
use
agil
seri
system
reversedphas
rp
column
mm
shimadzu
japan
mobil
phase
flow
rate
mlmin
ms
analysi
perform
use
esquir
esi
ion
trap
mass
spectromet
bruker
usa
equip
esquir
control
softwar
mass
spectra
acquir
process
use
softwar
provid
manufactur
posit
ion
mode
msm
analysi
select
work
follow
condit
capillari
voltag
kv
capillari
temperatur
nebul
ga
pressur
psi
dri
ga
flow
rate
lmin
scan
rang
mz
maximum
inject
time
ms
two
scan
event
prescrib
run
sequenti
mass
spectromet
marrow
examin
adipogen
potenti
bone
marrow
aspir
steril
either
side
bilater
iliac
crest
rabbit
use
preheparin
flexibl
plastic
tube
affix
syring
contain
ml
heparin
solut
uml
marrow
mononuclear
cell
mnc
isol
discontinu
gradient
centrifug
ficol
densiti
gml
g
minut
room
temperatur
isol
mnc
cultur
mesenchym
stem
cell
msc
basal
medium
contain
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
fb
mixtur
penicillin
streptomycin
neomycin
invitrogen
corpor
carlsbad
usa
incub
humidifi
three
day
medium
chang
nonadher
hematopoiet
cell
discard
afterward
medium
chang
week
two
week
two
week
later
cell
seed
densiti
cultur
basal
medium
confluenc
one
week
thereaft
basal
medium
repalc
adipogen
medium
basal
medium
supplement
normal
hors
serum
nm
dexamethason
sigma
demark
cultur
two
week
week
cultur
cell
vitro
stain
oil
red
coloni
cotain
adipocyt
posit
oil
red
consid
adipocyt
coloni
percentag
adipocyt
coloni
per
total
coloni
number
adipocyt
positvi
coloni
adipogen
potenti
index
determin
microscop
coloni
defin
distinct
group
cell
repres
derect
desced
msc
present
cultur
start
rabbit
group
sacrif
week
post
induct
respect
bodi
weight
rabbit
sacrific
document
surviv
condit
throughout
experi
period
group
record
examin
lesion
sacrific
use
overdos
sodium
pentobarbiton
decalcifi
proxim
femor
sampl
embed
paraffin
cut
section
along
coron
plane
histopatholog
examin
hematoxylin
eosin
h
e
stain
identif
lesion
perform
use
establish
criteria
ie
diffus
presenc
empti
lacuna
pyknot
nuclei
osteocyt
trabecula
accompani
surround
necrot
bone
marrow
rabbit
least
one
lesion
area
consid
lesion
consid
incid
defin
number
rabbit
divid
number
total
rabbit
group
extent
defin
number
lesion
per
rabbit
examin
thrombot
vessel
count
intravascular
thrombosi
fifteen
success
slice
dissect
proxim
part
bilater
femur
sampl
rabbit
chosen
summat
histopatholog
index
intravascular
thrombosi
ie
thrombot
vessl
count
usng
microscop
imag
system
zeiss
aixoplan
spot
rt
digit
camera
zeiss
germani
examin
fat
cell
area
fraction
extravascular
lipiddeposit
fifteen
success
slice
dissect
proxim
part
bilater
femur
sampl
rabbit
calcul
averag
fat
cell
area
fraction
histopatholog
index
extravascular
lipid
deposit
defin
total
marrow
fat
cell
area
normal
total
marrow
tissu
area
slice
marrow
fat
cell
easili
identifi
profil
quantifi
use
microscop
imag
system
zeiss
aixoplan
spot
rt
digit
camera
zeiss
germani
imag
analysi
softwar
imagej
nih
usa
intravascular
thrombosi
index
thrombot
vessl
count
extravascular
lipiddeposit
index
fat
cell
area
fraction
also
histo
morphometr
quantifi
human
umbil
vein
endotheli
cell
huvec
sciencel
research
laboratori
usa
maintain
commerci
endotheli
cell
medium
sciencel
research
laboratori
usa
huvec
incub
humidifi
atmospher
contain
pass
everi
three
day
huvec
cultur
plate
densiti
allow
grow
desir
confluenc
cell
incub
lp
escherichia
coli
sigmaaldrich
inc
usa
concentr
hour
incub
lp
huvec
pretreat
hour
icaritin
hplc
puriti
semisynthesi
shenzhen
research
institut
tsinghua
univers
china
indcut
group
low
dose
group
middl
dose
group
high
dose
group
parent
compound
ef
control
group
defin
nonlpsincub
cell
without
icaritin
pretreat
dimethyl
sulfoxid
dmso
icaritin
lp
dissolv
use
dmso
content
dmso
never
exceed
group
base
establish
protocol
manufactur
supern
solubl
tm
measur
use
commerci
human
thrombomodulin
elisa
kit
abcam
uk
experi
perform
triplic
nih
cell
grown
phenol
redfre
dulbecco
modifi
eagl
medium
gibco
usa
calf
serum
base
establish
adipogen
differenti
protocol
specif
medium
icaritin
indcut
group
low
dose
group
middl
dose
group
high
dose
group
parent
compound
ef
ad
medium
full
cours
differenti
control
group
defin
nonsteroidincub
cell
without
icaritin
treatment
dmso
icaritin
dexamethason
dissolv
use
dmso
content
dmso
never
exceed
group
medium
chang
everi
day
one
week
later
cell
wash
phosphatebuff
salin
pb
twice
stain
oil
red
solut
hour
room
temperatur
stain
oil
red
elut
isopropanol
cell
wash
optic
densiti
od
solut
nm
measur
experi
perform
triplic
incid
compar
use
fisher
exact
probabl
test
crosssect
quantif
data
express
examin
use
analysi
covari
ancova
bodi
weight
covari
variabl
elimin
influenc
measur
result
use
lsd
post
hoc
multipl
comparison
longitudin
quantif
data
analyz
use
anova
repeat
measur
bodi
weight
covari
variabl
elimin
influenc
measur
result
use
lsd
post
hoc
multipl
comparison
vitro
data
evalu
anova
use
lsd
post
hoc
multipl
comparison
statist
analysi
perform
use
spss
statist
signific
compaison
set
p
neither
organ
bleed
death
found
group
throughout
experiment
period
either
alt
ast
index
hepatocyt
injuri
significantli
chang
baselin
among
group
except
moder
increas
week
con
group
throughout
experiment
period
figur
lesion
found
week
post
induct
group
lesion
histopatholog
character
trabecular
bone
contain
consider
empti
lacuna
figur
incid
con
group
lef
group
mef
group
hef
group
respect
fisher
exact
probabl
test
show
incid
lef
mef
hef
group
significantli
lower
con
group
p
incid
mef
hef
group
significantli
lower
lef
group
p
wherea
differ
incid
found
mef
hef
group
p
signific
differ
extent
among
con
group
lef
group
mef
group
hef
group
figur
intravascular
histopatholog
contribut
event
histopatholog
thrombi
predominantli
found
small
marrow
vessel
con
group
sinc
week
post
induct
figur
thrombot
vessel
count
con
group
increas
peak
level
week
post
induciton
maintain
week
post
indcut
signific
differ
chang
pattern
con
group
three
ef
group
increas
thrombot
vessel
count
con
group
either
attenu
lef
group
prevent
mef
hef
group
throughout
experiment
period
fisher
exact
probabl
test
show
order
thrombot
vessel
count
week
post
indctuion
smilar
week
post
indctuion
ie
con
lef
mef
hef
figur
mechanist
tm
con
group
present
signific
increas
week
post
induct
p
declin
toward
baselin
signific
differ
chang
pattern
con
group
three
ef
group
p
lef
vs
con
p
mef
vs
con
hef
vs
con
especi
signific
increas
tm
con
group
either
attenu
lef
group
almost
prevent
mef
hef
group
week
post
induct
figur
extravascular
histopatholog
contribut
event
histopatholog
marrow
predominantli
occupi
numer
fat
cell
con
group
induct
figur
fat
cell
area
fraction
con
group
increas
signficantli
week
post
induciton
maintain
week
post
indcut
p
signific
differ
chang
pattern
con
group
three
ef
group
significantli
increas
fat
cell
area
fraction
con
group
either
attenu
lef
group
prevent
mef
hef
group
throughout
experiment
period
fisher
exact
probabl
test
show
order
fat
cell
area
fraction
week
post
indctuion
smilar
week
post
indctuion
ie
con
lef
mef
hef
figur
mechanist
adipocyt
posit
coloni
con
group
increas
significantli
week
post
induct
p
moder
restor
toward
baselin
signific
differ
chang
pattern
con
group
three
ef
group
p
lef
vs
con
p
mef
vs
con
hef
vs
con
especi
signific
increas
adipocyt
posit
coloni
either
attenu
lef
group
almost
prevent
mef
hef
group
week
post
induct
figur
pep
con
group
decreas
significantli
week
postinduct
p
significantli
increas
baselin
week
postinduct
p
signific
differ
chang
pattern
pep
time
con
group
three
ef
group
p
lef
vs
con
p
mef
vs
con
hef
vs
con
particular
signific
decreas
pep
con
group
attenu
lef
group
almost
prevent
mef
hef
group
week
post
induct
figur
total
ion
chromatogram
full
scan
mode
gener
hplcuvmsm
compar
blank
sera
con
group
obvious
peak
min
sera
three
ef
group
figur
structur
identifi
icaritin
follow
step
mobil
phase
elut
standard
icaritin
also
wash
retent
time
figur
mz
mna
icaritin
select
subsequ
select
ion
chromatographi
sic
peak
min
also
present
figur
ms
show
mass
weight
ion
mz
mna
absenc
exhibit
exist
prenyl
chromatographi
figur
firmli
confirm
structur
icaritin
addit
seven
flavonoid
compound
found
absent
hplc
profil
also
shown
sic
profil
accord
mass
weight
endotheli
cell
damag
model
supern
solubl
tm
endotoxin
induct
group
significantli
higher
control
group
p
wherea
icaritin
dosedepend
lower
supern
solubl
tm
three
differ
dosag
compar
induct
group
p
figur
seven
prototyp
flavonoid
ef
concentr
could
decreas
supern
solubl
tm
compar
induct
group
figur
preadipocyt
lipid
deposit
model
optic
densiti
destain
oil
red
stain
induct
group
significantli
higher
control
group
p
wherea
icaritin
dosedepend
lower
optic
densiti
three
differ
dosag
compar
induct
group
p
figur
differ
shown
seven
prototyp
flavonoid
ef
concentr
induct
group
optic
densiti
oil
red
stain
figur
result
calcul
incid
indic
ef
potenti
phytotherapeut
agent
reduc
risk
steroidassoci
dosedepend
manner
also
provid
experiment
explan
previou
clinic
find
preval
lower
patient
recov
sar
frequent
prescrib
crude
extract
epimedium
rehabilit
southern
china
seldom
prescrib
crude
extract
epimedium
northern
china
hand
signific
differ
extent
among
group
suggest
threshold
beyond
develop
lesion
initi
consist
find
report
publish
studi
experiment
studi
also
indic
threshold
reach
prevent
ef
littl
effect
develop
vascular
toxic
eg
organ
bleed
major
concern
administr
combin
anticoagul
lipidlow
agent
prevent
steroidinduc
develop
even
though
pharmaceut
combin
strategi
experiment
confirm
efficaci
avail
experiment
record
present
studi
indic
ef
safe
vascular
system
throughout
observ
period
evidenc
neither
bleed
bleedingrel
death
employ
three
dosag
regimen
addit
hepat
safeti
also
import
concern
present
studi
moder
nonsignific
increas
alt
ast
hepatocyt
injur
index
found
con
group
induct
combin
endotoxin
steroid
understand
sinc
endotoxin
report
detriment
hepatocyt
steroid
believ
lead
elev
lipogenesi
overburden
lipid
transport
hepatocyt
alt
ast
significantli
chang
baselin
compar
con
group
among
three
dosag
group
indic
hepat
safeti
ef
histopatholog
examin
suggest
ef
abl
dosedepend
inhibit
extravascular
lipid
deposit
evidenc
signific
increas
fat
cell
area
fraction
con
group
attenu
lef
group
prevent
mef
hef
group
pathogenesi
extravascular
lipid
deposit
earli
stage
steroidassoci
develop
elev
adipogenesi
import
extravascular
contribut
event
term
evalu
condit
adipogenesi
studi
high
level
adipocyt
posit
coloni
adipogen
potenti
index
consid
reflect
excess
adipogenesi
present
studi
result
show
excess
adipogenesi
occur
earli
stage
steroidassoci
develop
evidenc
significantli
increas
level
adipocyt
posit
coloni
con
group
week
post
induct
experiment
find
also
consist
previous
publish
studi
result
also
indic
ef
abl
dosedepend
counteract
elev
adipogenesi
evidenc
find
signific
increas
adipocyt
posit
coloni
con
group
attenu
lef
group
almost
prevent
mef
hef
group
week
post
induct
result
suggest
ef
abl
dosedepend
inhibit
intravascular
thrombosi
evidenc
find
increas
thrombot
vessel
count
con
group
attenu
lef
group
prevent
mef
hef
group
throughout
experiment
period
pathogenesi
intravascular
thrombosi
endothelium
injuri
recogn
import
initi
contribut
event
vascular
diseas
solubl
tm
plasma
index
endotheli
injuri
endothelium
tm
cell
surfac
glycoprotein
primarili
express
endotheli
cell
along
protein
c
play
role
counteract
hypercoagul
hypofibrinolysi
endotheli
cell
injuri
maintain
balanc
coagul
fibrinolysi
present
studi
signific
increas
tm
con
group
week
post
induct
found
also
correspond
publish
studi
result
also
indic
ef
abl
dosedepend
protect
endothelium
injur
evidenc
fact
significantli
increas
tm
con
group
either
attenu
lef
group
almost
prevent
mef
hef
group
week
post
induct
gener
consensu
local
vascular
suppli
key
provid
oxygen
nutrient
meet
requir
homeostat
tissu
metabol
repair
pep
paramet
dynam
contrastenhanc
mri
may
reflect
vascular
quantiti
vascular
suppli
present
studi
significantli
decreas
pep
con
group
week
postinduct
indic
insuffici
vascular
perfus
earli
stage
result
also
indic
ef
abl
dosedepend
maintain
vascular
quantiti
earli
stage
evidenc
find
ie
significantli
decreas
pep
con
group
attenu
lef
group
almost
prevent
hef
group
week
postinduct
ef
mainli
consist
seven
flavonoid
glycosid
common
stem
nuclear
question
ef
exert
effect
cellular
target
one
hand
icaritin
major
intestin
metabolit
present
studi
detect
sera
rabbit
treat
ef
wherea
seven
flavonoid
glycosid
detect
indic
seven
flavonoid
molecul
ef
intestin
metabol
icaritin
figur
find
also
consist
recent
studi
icaritin
primari
intestin
metabolit
prenyl
flavonoid
epimedium
hand
unpublish
data
demonstr
neither
measur
protect
effect
ef
endotoxininduc
damag
human
umbil
vein
endotheli
cell
measur
inhibit
effect
ef
steroidinduc
lipid
deposit
preadipocyt
data
shown
vitro
data
human
umbil
vein
endotheli
cell
model
present
studi
show
dosedepend
measur
protect
effect
icaritin
endotoxininduc
damag
evidenc
dosedepend
low
supern
solubl
tm
icaritin
group
three
differ
dosag
compar
induct
group
howev
differ
found
seven
parent
flavonoid
ef
induct
group
supern
solubl
tm
addit
vitro
data
preadipocyt
model
present
studi
show
dosedepend
measur
inhibit
effect
icaritin
steroidinduc
lipid
deposit
evidenc
dosedepend
low
oil
red
stain
icaritin
group
three
differ
dosag
compar
control
group
differ
found
seven
flavonoid
ef
induct
group
oil
red
stain
two
evid
consist
hplcuvmsm
find
studi
suggest
ef
compound
exert
prevent
effect
via
direct
action
potenti
cellular
target
addit
recent
publish
anim
studi
demonstr
icaritin
metabolit
ef
inhibit
thrombosi
lipiddeposit
reduc
incid
steroidassoci
dosedepend
manner
impli
icaritin
might
bioactiv
molecul
serv
common
substanc
basi
seven
flavonoid
glycosid
common
stem
nuclear
ef
though
suffici
evid
conclud
icaritin
found
serum
ef
administr
inde
caus
observ
prevent
effect
ef
futur
experiment
studi
use
steroidassoci
model
design
test
hypothesi
ef
inhibit
thrombosi
lipiddeposit
reduc
incid
steroidassoci
osteonecrosi
mainli
via
common
metabolit
icaritin
glycosidas
thought
one
main
enzym
hydrolyz
flavonoid
glycosid
correspond
aglycon
intestin
gluconolacton
broad
specif
glycosidas
inhibitor
caus
limit
hydrolysi
flavonoid
glycosid
thu
gluconolacton
could
employ
limit
hydrolysi
ef
result
prevent
format
icaritin
ef
see
ef
could
reduc
incid
steroidassoci
osteonecrosi
exist
gluconolacton
hypothesi
would
confirm
definit
facilit
understand
basic
biolog
scienc
chemistri
metabol
multicompon
ef
also
help
explor
molecular
mechan
ef
reduc
risk
steroidassoci
furthermor
novel
small
molecul
icaritin
would
emerg
effect
prevent
steroidassoci
constitut
ef
compound
exert
dosedepend
effect
inhibit
thrombosi
lipiddeposit
accordingli
reduc
incid
steroidassoci
rabbit
via
direct
action
potenti
cellular
target
underli
mechan
could
explain
counteract
effect
endothelium
injuri
excess
adipogenesi
find
encourag
design
clinic
trial
investig
potenti
ef
prevent
steroidassoci
